APA (7th ed.) Citation

DeLurgio, D. B., Ferguson, E., Gill, J., Blauth, C., Oza, S., Mostovych, M., . . . Crossen, K. (2020). Convergence of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Persistent AF (CONVERGE Trial): Rationale and design. The American heart journal, 224, 182-191. https://doi.org/10.1016/j.ahj.2020.02.016

Chicago Style (17th ed.) Citation

DeLurgio, David B., Edward Ferguson, Jaswinder Gill, Christopher Blauth, Saumil Oza, Mark Mostovych, Yashasvi Awasthi, Nfii Ndikintum, and Karl Crossen. "Convergence of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Persistent AF (CONVERGE Trial): Rationale and Design." The American Heart Journal 224 (2020): 182-191. https://doi.org/10.1016/j.ahj.2020.02.016.

MLA (9th ed.) Citation

DeLurgio, David B., et al. "Convergence of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Persistent AF (CONVERGE Trial): Rationale and Design." The American Heart Journal, vol. 224, 2020, pp. 182-191, https://doi.org/10.1016/j.ahj.2020.02.016.